Respiratory

DC 6846

Sarcoidosis

Educational use only. Not legal or medical advice. Read 38 CFR §4.97 on eCFR
Diagnostic Code
6846
CFR Section
§4.97 — Respiratory

Rating Tiers

100%

Cor pulmonale, or; cardiac involvement with congestive heart failure, or; progressive pulmonary disease with fever, night sweats, and weight loss despite treatment

60%

Pulmonary involvement requiring systemic high dose (therapeutic) corticosteroids for control

30%

Pulmonary involvement with persistent symptoms requiring chronic low dose (maintenance) or intermittent corticosteroids

0%

Chronic hilar adenopathy or stable lung infiltrates without symptoms or physiologic impairment

Rated Under Formula

This condition is rated using the §4.97 general rating formula.

What Raters Look For

Based on M21-1 adjudication criteria for Respiratory conditions. These are the factors a VA rater evaluates when assigning a rating percentage.

M21-1 III.iv.4.B
  • •Pulmonary function test results: FEV1 (% of predicted), FVC, FEV1/FVC ratio, and DLCO
  • •Exercise tolerance in METs (metabolic equivalents) if cardiac limitation is also relevant
  • •Frequency of exacerbations requiring medical visits, oral steroids, or hospitalization
  • •Oxygen therapy use — whether prescribed and under what conditions
  • •Sleep study results and AHI score if sleep apnea is claimed
  • •Medication regimen: inhalers, systemic steroids, biologics
  • •Smoking history (noted but not used to reduce rating)
NoteFor sleep apnea, raters look specifically at whether a CPAP/BiPAP is required — that alone meets the 50% rating criteria under DC 6847.